Related Experiment Videos

Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study)

U T Larsen1, B Juhl, O Hein-Sörensen

  • 1Department of Anesthesiology, University Hospital of Aarhus, Denmark.

Insights

Anesthetic complications, particularly those resembling malignant hyperthermia, are frequent in Duchenne muscular dystrophy patients. Succinylcholine use is strongly linked to these severe adverse events, even before diagnosis.

Area of Science:

  • Anesthesiology
  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting muscle function.
  • Anesthetic management in DMD patients requires careful consideration due to potential complications.
  • Previous reports suggest risks associated with certain anesthetic agents in DMD.

Observation:

  • This retrospective study analyzed 84 anesthetic procedures in 44 boys with DMD over 22 years.
  • Complications were evaluated following local analgesia and general anesthesia.
  • Case records from 15 different hospitals were reviewed.

Findings:

  • 19 local analgesia cases had no complications.
  • 18 of 65 general anesthetics resulted in minor or serious complications.
  • Complications included hyperthermia, abdominal pain, dark urine, and critical events mimicking malignant hyperthermia, predominantly linked to succinylcholine use.

Implications:

  • Succinylcholine use in DMD patients is associated with significant anesthetic risks, including hyperthermia and critical perioperative events.
  • These complications can occur even before a DMD diagnosis, highlighting the need for vigilance in pediatric anesthesia.
  • The continued use of succinylcholine in DMD patients, despite contraindications, warrants further investigation and stricter adherence to safety guidelines.

Related Concept Videos